Candel Therapeutics, Inc.
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase I…
Biotechnology
US, Needham [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Candel Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Candel Therapeutics, Inc. has no acquisition track records yet.